Wikipedia -WSS

Wikipedia

author：focus 2025-09-27 12:56:59 - browse：8

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Flu vaccine reformulation won't be easy, manufacturers warn

explore

WSS

TikTok, Instagram influencers need more rules for drug ads

Immunocompromised patients offer clues on chronic Covid

Dozens dead from Maui wildfires: What we know about the victims

Immunocompromised patients offer clues on chronic Covid

Immunocompromised patients offer clues on chronic Covid

Microsoft launches AI tool for clinical documentation through Epic

leisure time

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Tori Bowie and the unacceptable rates of Black maternal death

Health AI: on the border between health care and tech

Walensky prepares to leave CDC — and Congress — behind

Novo Nordisk touts Wegovy study, but still struggling with supply

The cancer drug shortage isn’t new — and neither are the solutions

The inclusion problem at the heart of rehabilitation research

The high cost of giving birth even with insurance

BMS, looking to build heart drug business, turns to AI for diagnosis

BioMarin wins approval for gene therapy to treat hemophilia A

Illinois Supreme Court finds assault weapons ban constitutional

knowledge

Dozens dead from Maui wildfires: What we know about the victims

FDA sets aggressive timeline for overhauling inspection procedures

Printout prescription drug information shouldn’t go digital

Novo Nordisk touts Wegovy study, but still struggling with supply

FDA endorses new sterilization method for medical devices

Megan Rapinoe shares emotional post following US Women's World Cup exit

focus

explore

Wikipedia

focus